Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–28 of 28 pages matching "alzheimers"

🧪 Novartis Alzheimer's Disease Phase 2 Trial (NCT07094516)KG

clinical · 4,079 words · 61 hyp28 ana67 exp

🧪 Rotigotine and Rivastigmine Combination Therapy for Alzheimer's Disease (NCT06702124)KG

clinical · 3,657 words · 59 hyp35 ana50 exp

🧪 BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer's DiseaseKG

clinical · 3,627 words · 38 hyp21 ana64 exp

🧪 LHP588: P. gingivalis Targeting for Alzheimer's Disease (NCT06847321)KG

clinical · 2,741 words · 40 hyp27 ana50 exp

🧪 EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer's DiseaseKG

clinical · 2,740 words · 35 hyp31 ana50 exp

🧪 Interleukin-2 Phase 2 (NCT06096090) — Immunomodulation for ADKG

clinical · 2,399 words · 18 hyp11 ana6 exp

🧪 [F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disease PredictionKG

clinical · 2,349 words · 30 hyp24 ana49 exp

🧪 CBD (Cannabidiol) for Alzheimer's Disease Agitation - NCT06014424KG

clinical · 2,012 words · 35 hyp22 ana63 exp

🧪 UB-311 Alzheimer's Vaccination TrialKG

clinical · 1,914 words · 19 hyp8 ana2 exp

🧪 Biogen Alzheimer's Disease Phase 2 Trial (NCT05399888)KG

clinical · 1,740 words · 30 hyp24 ana52 exp

🧪 Ozanimod for Alzheimer's Disease (NCT06862960)KG

clinical · 1,602 words · 37 hyp20 ana49 exp

🧪 ITI-1284 for Alzheimer's Agitation (NCT06651567)KG

clinical · 1,520 words · 7 ana2 exp

🧪 Exciva Alzheimer's Disease Phase 2/3 TrialKG

clinical · 1,443 words · 39 hyp24 ana48 exp

🧪 Recombinant Human Serum Albumin for Alzheimer's Disease (NCT06489015)KG

clinical · 1,369 words · 32 hyp28 ana54 exp

🧪 NCT06582706: Nicotinic Acid for Alzheimer's DiseaseKG

clinical · 1,353 words · 45 hyp21 ana60 exp

🧪 ITI-1284 for Alzheimer's Disease Psychosis (NCT06540833)KG

clinical · 1,331 words · 28 hyp20 ana49 exp

🧪 ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)KG

clinical · 1,190 words · 28 hyp20 ana49 exp

🧪 NRTIs for Alzheimer's Disease - Phase 1 (NCT07210528)KG

clinical · 1,158 words · 30 hyp24 ana49 exp

🧪 Guanfacine NorAD - Phase 3 Trial for Alzheimer's DiseaseKG

clinical · 1,008 words · 33 hyp25 ana52 exp

🧪 Probiotics in Mild Alzheimer's Disease (NCT06181513)KG

clinical · 970 words · 30 hyp20 ana49 exp

🧪 NRTIs for Alzheimer's Disease: Targeting Type-I Interferon-Driven Neuroinflammation (NCT04500847)KG

clinical · 966 words · 38 hyp32 ana60 exp

🧪 NCT07279740: Methylphenidate + tDCS for ADKG

clinical · 930 words · 8 hyp5 ana13 exp

🧪 NCT03875638 - Levetiracetam for Alzheimer's DiseaseKG

clinical · 870 words · 29 hyp20 ana49 exp

🧪 SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheimer's Disease (NCT05081219)KG

clinical · 867 words · 33 hyp21 ana50 exp

🧪 SHR-1707 for Alzheimer's Disease (NCT06199037)KG

clinical · 788 words · 37 hyp21 ana53 exp

🧪 EI-1071 Immunomodulator for Alzheimer's Disease (NCT06745583)KG

clinical · 729 words · 51 hyp24 ana56 exp

🧪 Foralumab Phase 2 Trial for Alzheimer's DiseaseKG

clinical · 680 words · 34 hyp27 ana52 exp

🧪 Centella asiatica Phase 1 Trial for Alzheimer's Disease (NCT05591027)KG

clinical · 595 words · 33 hyp24 ana49 exp